Browse the evidence

Ultrasound measurement of vastus lateralis (VL) muscle thickness, combined with body mass, provides a statistically accurate and ecologically valid prediction of whole-body and thigh fat-free mass (FFM) in resistance-trained men, serving as a viable alternative to DXA.

If you are a resistance-trained man, you can track your muscle gains using a portable ultrasound device focused on your vastus lateralis (side thigh) and your body weight. The study provides a specific formula: Whole Body FFM = -1.657 + (0.719 * Body Mass in kg) + (0.416 * VL Thickness in mm). This method is as accurate as DXA for this group and can be done in a gym setting, allowing you to monitor progress without expensive medical imaging.

In older adults, resistance training combined with whey protein supplementation induces distinct skeletal muscle metabolic adaptations—specifically upregulation of tryptophan-indole metabolites, branched-chain amino acids (leucine, isoleucine, valine), and urea cycle intermediates—in individuals who exhibit high hypertrophic responsiveness (upper tertile).

For older adults seeking muscle growth, resistance training combined with adequate protein (whey) is effective, but results vary significantly. High responders exhibit specific metabolic adaptations, including increased levels of tryptophan, branched-chain amino acids, and urea cycle intermediates. This suggests that individual metabolic profiles play a key role in hypertrophic responsiveness, and those with lower responses may require different strategies or higher stimuli to achieve similar gains.

Modest combined improvements in sleep (11 min/day), physical activity (4.5 min/day MVPA), and nutrition (3 DQS points) are associated with a clinically meaningful 10% reduction in major adverse cardiovascular events (MACE).

You do not need to overhaul your entire life to significantly lower your heart disease risk. Instead, focus on making small, manageable improvements in three key areas every day: get 11 extra minutes of sleep, add 4.5 minutes of moderate-to-vigorous exercise (like brisk walking), and improve your diet quality by about 3 points (roughly adding 1/4 cup of vegetables). These modest, combined changes are associated with a 10% lower risk of major cardiovascular events.

Bariatric surgery (RYGB, SG, LAGB, BPD) significantly improves Type 2 Diabetes (T2DM) remission and lowers HbA1c levels compared to medical/lifestyle management (MT) in mid- to long-term follow-up.

For individuals with Type 2 Diabetes and obesity, bariatric surgery (specifically RYGB, SG, LAGB, or BPD) is significantly more effective than medical management or lifestyle changes alone for achieving diabetes remission and lowering HbA1c levels over the long term. While surgery carries risks and requires lifelong monitoring, it offers a superior path to metabolic health compared to non-surgical approaches for this population.

Roux-en-Y Gastric Bypass (RYGB) is the most favorable option for managing BMI and triglyceride (TG) levels in the mid-term, and is the second-best option for T2DM remission.

Roux-en-Y Gastric Bypass (RYGB) is a highly effective and well-studied surgical option for managing Type 2 Diabetes, particularly for improving BMI and triglyceride levels. It offers significant benefits for metabolic health and is a favorable choice for patients seeking a balance between efficacy and established surgical data.

Higher neighborhood-level availability of calories, carbohydrates, total fat, and saturated fat is positively associated with increased odds of being overweight in adults.

Your local food environment significantly impacts your weight risk. If you live in an area with high-calorie, high-fat food options, your odds of being overweight increase. To mitigate this, prioritize living in or visiting areas with more green space and lower saturated fat contributions, and be aware that 'healthy' labels on outlets may not reflect actual macronutrient content.

Higher scores on the Dietary Index for Gut Microbiota (DI-GM), specifically driven by beneficial components, are associated with significantly reduced all-cause and cardiovascular mortality in individuals with Cardiovascular-Kidney-Metabolic (CKM) syndrome stages 0-3.

For individuals with early-stage metabolic or kidney risks, prioritizing foods known to support gut health—such as fiber, fermented dairy, whole grains, and specific fruits/vegetables—may lower the risk of death from heart or other causes. This benefit appears distinct from just general dietary quality, suggesting specific gut-microbiome interactions are key.

High unfavorable dietary components (processed meats, red meats, refined grains, high-fat patterns) are associated with increased all-cause mortality but show no significant association with cardiovascular mortality after full adjustment.

Avoiding processed meats, refined grains, and high-fat patterns is important for overall survival, even if it doesn't directly predict heart disease death in this specific population. It contributes to general longevity.

Adherence to high dietary risk patterns (high DII score, high saturated fat/sodium, low fiber/omega-3) is significantly associated with increased odds of Major Adverse Cardiovascular Events (MACE), stroke, and cardiovascular mortality in patients with angiocardiopathy.

For patients with angiocardiopathy, adopting a low-inflammatory diet (low DII score) is strongly associated with reduced risk of major cardiovascular events, stroke, and death. This involves increasing intake of fruits, vegetables, fiber, and omega-3s, while reducing saturated fats, sodium, and added sugars. While this study is observational, the strong associations suggest that dietary optimization is a key component of managing cardiovascular risk in this population.

Treating cardiovascular, kidney, and metabolic diseases as interconnected entities sharing common pathophysiological mechanisms (CKM syndrome) is superior to treating them as separate, isolated conditions.

If you have high blood pressure, high blood sugar, and kidney issues, do not treat them in isolation. Seek a care model that addresses all three simultaneously, as they likely stem from the same underlying metabolic and inflammatory drivers. This integrated approach is the current standard of care for preventing progression to heart failure or end-stage kidney disease.

Increasing lean body mass (LBM) below 52.26 kg is negatively associated with the risk of osteoarthritis, suggesting a protective effect, whereas increasing LBM above this threshold provides no statistically significant additional benefit.

If you have low muscle mass, building it up to around 52 kg (for women, likely higher for men depending on height/build, but the study uses absolute kg) can significantly lower your risk of developing osteoarthritis. Once you have a substantial amount of lean mass, adding more muscle won't necessarily protect your joints further, but maintaining it is still important for overall health. Focus on resistance training to build muscle if you are currently lean.

Adherence to the American Heart Association's Life's Essential 8 (LE8) score is inversely associated with the risk of developing new-onset abdominal aortic aneurysm (AAA).

To lower your risk of abdominal aortic aneurysm, focus on optimizing your overall cardiovascular health using the Life's Essential 8 framework. This means aiming for ideal levels in blood pressure, cholesterol, blood sugar, and BMI, while never smoking, staying physically active, eating a healthy diet, and getting 7-9 hours of sleep. You don't need to be perfect; even small, consistent improvements in these areas can significantly reduce your risk over time. Prioritize quitting smoking and increasing physical activity, as these had the strongest individual effects in the study.

Metabolic bariatric surgery is the most effective therapy for severe obesity, providing greater weight loss and mortality reduction than pharmacotherapy.

For severe obesity, surgery offers the highest chance of significant, sustained weight loss and resolution of comorbidities. Discuss eligibility with a bariatric specialist.

Tirzepatide treatment in adults with obesity or overweight results in a body composition change where approximately 75% of total weight loss is fat mass and 25% is lean mass, a proportion consistent with placebo and other weight loss modalities.

If you take tirzepatide, expect to lose about 3 pounds of fat for every 1 pound of muscle. This is the same ratio you would get from dieting alone. You do not need to worry that the medication is uniquely damaging to your muscles. To protect your strength, focus on the recommended lifestyle changes: eat 500 calories less per day and move for 150 minutes a week.

GLP-1 receptor agonists for obesity treatment cause significant loss of lean body mass (including muscle) and bone density, with muscle loss accounting for approximately 20% of total weight reduction in the absence of structured resistance training.

If you are taking GLP-1s for weight loss, you must incorporate resistance training (weight lifting or bodyweight exercises) at least 2-3 times per week. Without this, roughly 20% of the weight you lose will be muscle, not just fat. Ensure you are eating enough protein to support muscle retention during the caloric deficit.

GLP-1 receptor agonists for obesity treatment cause significant loss of lean body mass (approximately 38% of total weight loss) and muscle mass, increasing the risk of sarcopenia and bone loss, particularly in the absence of structured resistance training and adequate protein intake.

If you are taking a GLP-1 medication for weight loss, expect to lose some muscle along with fat. To protect your strength and metabolism, you must prioritize resistance training (weight lifting or bodyweight exercises) and ensure you are eating enough protein. Without these steps, you risk losing significant muscle mass, which can happen with any rapid weight loss method.

Regular physical exercise prevents age-related skeletal muscle dysfunction, including loss of strength and mitochondrial capacity, by inducing structural remodeling and metabolic adaptations.

Start or maintain regular physical activity, combining aerobic and resistance exercises, to protect your muscles from age-related decline. This is one of the most effective ways to maintain strength, mitochondrial health, and metabolic function as you age.

GLP-1 receptor agonists for obesity treatment cause significant loss of lean body mass (approximately 20-25% of total weight reduction in men and 10-15% in women) and bone density, particularly when rapid weight loss occurs without structured resistance training.

If you are taking a GLP-1 medication for weight loss, you will likely lose some muscle along with fat. To protect your strength and metabolism, you must engage in resistance training (weight lifting) and ensure you are eating enough protein. This is especially important if you are losing weight quickly.

Regular physical activity, including aerobic, resistance, balance, and dual-task training, reduces the risk of dementia and cognitive decline by enhancing neurogenesis, improving cerebral blood flow, and increasing brain-derived neurotrophic factor (BDNF).

Aim for 150-300 minutes of moderate aerobic activity (like brisk walking) or 75-150 minutes of vigorous activity per week. Add strength and balance exercises twice a week. If you prefer cultural practices like Tai Chi or yoga, these are excellent alternatives that also support cognitive health. Start with what you enjoy and gradually increase intensity.

Obesity increases the risk and severity of acute pancreatitis (AP) through mechanisms including gallstone formation, hypertriglyceridemia-induced lipotoxicity, and intrapancreatic fat infiltration.

If you have obesity, your risk of acute pancreatitis is significantly higher due to factors like gallstones and fat breakdown products. Losing weight, particularly visceral fat, can reduce this risk.

Higher consumption of ultra-processed foods (UPFs) is associated with an increased risk of developing type 2 diabetes mellitus (T2DM), with hazard ratios typically ranging from 1.12 to 1.53 for incremental increases in UPF intake.

Limit your intake of ultra-processed foods, particularly those high in added sugars, saturated fats, and specific additives like emulsifiers (e.g., carrageenan) or containing endocrine disruptors from packaging (e.g., BPA). Focus on reducing sugary beverages and processed meats, as these show the strongest link to T2DM risk, while noting that some processed items like whole grain breads may not carry the same risk.

Time since Type 2 Diabetes diagnosis is a significant moderator of absolute peak oxygen uptake, with longer duration associated with greater reductions in fitness.

The longer you have Type 2 Diabetes, the more your maximum oxygen uptake tends to drop. However, this decline is gradual. Prioritize exercise early in your diagnosis to preserve fitness, as the most significant drops may occur within the first 5 years.

Adherence to a Mediterranean diet (MedDiet) mitigates the increased risk of type 2 diabetes and metabolic dysfunction associated with the TCF7L2 rs7903146 T-allele, effectively neutralizing the genetic predisposition when adherence is high.

If you carry the TCF7L2 rs7903146 T-allele (a common genetic variant linked to higher diabetes risk), strict adherence to a Mediterranean-style diet is your most powerful tool. It doesn't just help; it specifically neutralizes the genetic disadvantage, keeping your weight, waist circumference, and diabetes risk in check. Focus on high adherence to this pattern rather than just isolated nutrients.

Reduced gut microbial diversity (alpha-diversity) and specific taxonomic shifts (e.g., depletion of Akkermansia muciniphila and Faecalibacterium prausnitzii) are consistently associated with obesity and metabolic syndrome, serving as a marker of a less resilient microbiome.

Focus on dietary patterns that support microbial diversity (e.g., fiber-rich diets) rather than seeking simple diagnostic ratios. A diverse diet supports a resilient microbiome, which is associated with better metabolic health.